Ardelyx | ARDX - Current Liabilities

Stock Price
6.23
Daily Change
-0.23 -3.56%
Monthly
-0.80%
Yearly
60.57%
Q2 Forecast
6.64

Ardelyx reported $109.57M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Amgen USD 24.96B 534M Mar/2026
Ardelyx USD 109.57M 20.96M Mar/2026
aTyr Pharma USD 11.7M 101.49M Mar/2026
Corcept Therapeutics USD 149.18M 16.9M Mar/2026
Curis USD 14.08M 5.3M Dec/2025
Sanofi EUR 28.35B 9.32B Dec/2025
TG Therapeutics USD 187.11M 33.35M Mar/2026
United Therapeutics USD 599.1M 38.5M Mar/2026
Xoma USD 28.3M 6.81M Sep/2025